Death by neglect as a deletional mechanism of peripheral tolerance. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Death by neglect as a deletional mechanism of peripheral tolerance.

Int Immunol. 1999 Aug;11(8):1225-38. Unique Identifier : AIDSLINE MED/99352253
Bertolino P; Trescol-Biemont MC; Thomas J; de St Groth BF; Pihlgren M; Marvel J; Rabourdin-Combe C; Ecole Normale Superieure de Lyon, INSERM U98, 46 Allee; d'Italie, 69364 Lyon Cedex 07, France.


Abstract: In contrast to most organs, the anatomy of the liver may allow naive CD8(+) T cells to make direct contact with liver parenchymal cells. We have previously shown, using a combination of TCR transgenic T cells specific for H-2 K(b) and hepatocytes expressing a transgenic H-2 K(b) molecule, that hepatocytes can induce antigen-specific activation and proliferation of naive CD8(+) T cells independently of CD28 co-stimulation. However, T cell activation by hepatocytes leads to premature T cell death and tolerance, both in vivo and in vitro. In this study, we investigated the mechanisms of T cell death induced by hepatocytes in vitro using primary hepatocytes to activate purified CD8(+) T cells. Neither Fas nor tumor necrosis factor receptor were involved, indicating that hepatocyte- induced death was distinct from activation-induced cell death. Before they started to divide, T cells activated by hepatocytes expressed lower levels of the bcl-x(L) survival gene and 30 times less IL-2 mRNA than CD8(+) cells activated by splenic antigen-presenting cells. Since CD28 co-stimulation increases both IL-2 and bcl-x(L) expression, this suggests that hepatocyte-activated T cells die by neglect because they fail to receive effective co-stimulatory signals. In agreement with this model, premature death promoted by hepatocytes could be prevented by cross-linking CD28. Survival after CD28 cross-linking correlated with increased IL-2 and bcl-x(L) expression, and sustained T cell proliferation, while cytotoxic T lymphocyte activity was prolonged as compared with cells stimulated without CD28 co-stimulation. This study confirms that high- affinity TCR transgenic antigen-specific CD8(+) T cells can be activated to proliferate and differentiate into cytotoxic effector cells. However, prolonged T cell survival and cytotoxicity required CD28 co-stimulation as well. To our knowledge, this is the first report suggesting that tolerance in the context of lack of CD28 co-stimulation can result from Fas-independent peripheral deletion rather than from anergy.
Keywords: JOURNAL ARTICLE Animal Antigens, CD28/IMMUNOLOGY/METABOLISM Apoptosis *Clonal Deletion Coculture Cytokines/BIOSYNTHESIS CD8-Positive T-Lymphocytes/IMMUNOLOGY/*PHYSIOLOGY Dendritic Cells/IMMUNOLOGY Interleukin-2/GENETICS/METABOLISM Liver/CYTOLOGY/*IMMUNOLOGY Lymphocyte Transformation Mice Mice, Inbred C57BL Mice, Transgenic Proto-Oncogene Proteins c-bcl-2/GENETICS/METABOLISM Receptors, Antigen, T-Cell, alpha-beta/GENETICS *Self Tolerance Support, Non-U.S. Gov't T-Lymphocytes, Cytotoxic/IMMUNOLOGYKWDjournalarticleanimalantigens,cd28/immunology/metabolismapoptosisKWDclonaldeletioncoculturecytokines/biosynthesiscd8-positivet-lymphocytes/immunology/KWDphysiologydendriticcells/immunologyinterleukin-2/genetics/metabolismliver/cytology/KWDimmunologylymphocytetransformationmicemice,inbredc57blmice,transgenicproto-oncogeneproteinsc-bcl-2/genetics/metabolismreceptors,antigen,t-cell,alpha-beta/geneticsKWDselftolerancesupport,non-uKWDsKWDgov'tt-lymphocytes,cytotoxic/immunology
991230
A99C1075

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .